Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Yue Ru Ji"'
Autor:
Zhou Xin Yang, Zhi-Bo Han, Yue Ru Ji, You Wei Wang, Lu Liang, Ying Chi, Shao Guang Yang, Li Na Li, Wei Feng Luo, Jian Ping Li, Dan Dan Chen, Wen Jing Du, Xiao Cang Cao, Guang Sheng Zhuo, Tao Wang, Zhong Chao Han
Publikováno v:
PLoS ONE, Vol 8, Iss 3, p e59354 (2013)
Mesenchymal stem cells (MSCs) reside in almost all of the body tissues, where they undergo self-renewal and multi-lineage differentiation. MSCs derived from different tissues share many similarities but also show some differences in term of biologica
Externí odkaz:
https://doaj.org/article/9b2ee6cfab7a4b92ab539a7cc1b04584
Publikováno v:
Zhongguo shi yan xue ye xue za zhi. 28(6)
Enhancer of zeste homolog 2(EZH2) is a histone methyltransferase which regulate gene expression through epigenetic machinery. The abnormal expression of EZH2 has been described in many cancer types. With in-depth study, it was found that EZH2 is invo
Autor:
Guo-Hui, Li, Ren-An, Chen, Yue-Ru, Ji, Wei-Wei, Qin, Yi, Chen, Wen-Qing, Wang, Cong, Liu, Nai-Cen, Zhou, Li, Liu
Publikováno v:
Zhongguo shi yan xue ye xue za zhi. 26(3)
To investigate the safety and efficacy of decitabine combined with CAG regimen in the treat-ment of newly diagnosed elderly patients with acute myeloid leukemia(AML).Fourty-nine patients with newly diagnosed acute myeloid leukemia (except M3) who wer
Autor:
Zhi Bo Han, Ying Chi, Yue Ru Ji, Li Fang Wang, Zhou Xin Yang, Wei Feng Luo, Zhongchao Han, Guang Sheng Zhuo, Jing Zhang, You Wei Wang, Li Na Li, Cai Dong Hu
Publikováno v:
Experimental and Therapeutic Medicine
Mesenchymal stem cells (MSC) are able to differentiate into cells of multiple lineage, and additionally act to modulate the immune response. Interleukin (IL)-9 is primarily produced by cluster of differentiation (CD)4+ T cells to regulate the immune
Publikováno v:
Zhongguo shi yan xue ye xue za zhi. 21(6)
The main aim of this study was to investigate the biological activities and immune modulation changes of chorionic villi mesenchymal stem cells (CV-MSC) after long term culture. The morphology of the CV-MSC of passage 3 and passage 9 were observed by
Publikováno v:
Zhongguo shi yan xue ye xue za zhi. 21(4)
This study was aimed to investigate the effect of IL-1β on hematopoietic support of human umbilical cord mesenchymal stem cells (hUC-MSC). 2×10(6) hUC-MSC were seeded in 75 cm(2) flasks, after adherence to wall for 2 h, 10 ng/ml IL-1β was added in
Autor:
Zhi-Bo, Han, You-Wei, Wang, Tao, Wang, Ying, Chi, Zhou-Xin, Yang, Yue-Ru, Ji, Lei, Meng, Ping, Yang, Zhong-Chao, Han
Publikováno v:
Zhongguo shi yan xue ye xue za zhi. 21(3)
Comparing to bone marrow mesenchymal stem cells (MSCs), placenta-derived MSCs have the advantages of adequate sources, low immunogenicity, little risk of viral contamination, and no ethical controversy, and thus possess a better prospect for clinical
Autor:
Zhou-Xin Yang, Lei Zhang, Hui Zhao, Yue-Ru Ji, Ying Chi, Youwei Wang, Zhongchao Han, Jinhan Wang, Zhibo Han
Publikováno v:
Cellular Physiology and Biochemistry, Vol 31, Iss 6, Pp 823-832 (2013)
Background: CD151 is highly expressed in breast cancer cells and has been shown to accelerate breast cancer by enhancing cell growth and motility, but its regulation is poorly understood. To explore post-translation regulation of CD151, for example m
Autor:
Li-Na, Li, Zhi-Bo, Han, You-Wei, Wang, Wei-Feng, Luo, Yue-Ru, Ji, Zhou-Xin, Yang, Li, Feng, Ren-Bin, Qi, Yang-Qiu, Li, Zhong-Chao, Han
Publikováno v:
Zhongguo shi yan xue ye xue za zhi. 20(4)
This study was aimed to explore whether the conditioned culture medium of human umbilical cord-derived mesenchymal stem cells (hUC-MSC) has supportive effects on hematopoiesis in vitro. hUC-MSC were cultured in 75 cm(2) culture flasks at a concentrat
Autor:
Zhi-Bo, Han, Zhou-Xin, Yang, Ying, Chi, You-Wei, Wang, Tao, Wang, Yue-Ru, Ji, Ping, Yang, Lei, Meng, Zhong-Chao, Han
Publikováno v:
Zhongguo shi yan xue ye xue za zhi. 20(3)
Because advantage of tissue origin and proliferation potential, the umbilical cord-derived mesenchymal stem cells (UC-MSC) and placental chorionic villous-derived mesenchymal stem cells (CV-MSC) have clinical application potential, as compared with b